<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="3169">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on February 08, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04694638</url>
  </required_header>
  <id_info>
    <org_study_id>20-003191</org_study_id>
    <nct_id>NCT04694638</nct_id>
  </id_info>
  <brief_title>Use of Combined Prone Positioning and High-Flow Nasal Cannula, and Non-invasive Positive Pressure Ventilation to Prevent Intubation in COVID-19 Infection</brief_title>
  <official_title>The Use of Combined Prone Positioning and High-Flow Nasal Cannula, and Non-invasive Positive Pressure Ventilation to Prevent Intubation in Acute Hypoxemic and/or Hypercapnic Respiratory Failure Secondary to COVID-19 Infection: A Feasibility, Safety Phase One, Open Label Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Mayo Clinic</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Mayo Clinic</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This research aims to understand if prone positioning combined with high-flow nasal cannula&#xD;
      (HFNC) or non-invasive positive pressure ventilation (NIPPV) safely reduce the rate of&#xD;
      intubation in acute hypoxemic and/or hypercapnic respiratory failure secondary to COVID-19&#xD;
      infection.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">May 21, 2020</start_date>
  <completion_date type="Anticipated">May 2021</completion_date>
  <primary_completion_date type="Anticipated">May 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <intervention_model_description>Feasibility study</intervention_model_description>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Rate of intubation</measure>
    <time_frame>1 year</time_frame>
    <description>Number of critically ill patients with acute hypoxemic and/or hypercapnic respiratory failure, secondary to COVID-19 infection to require intubation and mechanical ventilation</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Incidence of hypotension and cardiac arrhythmias and other nursing-related risks of combining prone positioning with high-flow nasal cannula and non-invasive positive pressure ventilation</measure>
    <time_frame>1 year</time_frame>
    <description>To evaluate the the incidence of hypotension and cardiac arrhythmias and other nursing-related risks of combining prone positioning with high-flow nasal cannula and non-invasive positive pressure ventilation.</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">24</enrollment>
  <condition>Prone Positioning</condition>
  <condition>Covid19</condition>
  <condition>Hypoxemic Respiratory Failure</condition>
  <condition>ARDS</condition>
  <condition>Non Invasive Ventilation</condition>
  <condition>High Flow Nasal Cannulla</condition>
  <arm_group>
    <arm_group_label>HFNC and NIPPV</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Combined use of prone positioning and non-invasive positive pressure ventilation (NIPPV) and high-flow nasal cannula (HFNC)</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Body position change</intervention_name>
    <description>combined use of prone positioning and high-flow nasal cannula (HFNC) and non-invasive positive pressure ventilation (NIPPV) can reduce the rate of intubation in acute hypoxemic and/or hypercapnic respiratory failure secondary to COVID-19 infection.</description>
    <arm_group_label>HFNC and NIPPV</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients with confirmed COVID19 infection or suspected COVID19 infection.&#xD;
&#xD;
          -  Patients requiring HFNC or NIPPV&#xD;
&#xD;
          -  Patients who are clinically stable and able to tolerate the changes in position that&#xD;
             are routinely conducted as part of the standard of care in the medical ICU.&#xD;
&#xD;
          -  Patient should be able to provide informed consent to the study. Any participant&#xD;
             speaking any language will be offered participation.&#xD;
&#xD;
          -  Able to actively participate in Assisted Manual Pronation Therapy per nursing&#xD;
             assessment.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
        Contraindication for prone positioning:&#xD;
&#xD;
          -  Intracranial pressure &gt;30 mm Hg or cerebral perfusion pressure &lt;60 mmHg&#xD;
&#xD;
          -  Massive hemoptysis requiring an immediate surgical or interventional radiology&#xD;
             procedure&#xD;
&#xD;
          -  Tracheal surgery or sternotomy during the previous 15 days&#xD;
&#xD;
          -  Serious facial trauma or facial surgery during the previous 15 days&#xD;
&#xD;
          -  Deep venous thrombosis treated for less than 2 days&#xD;
&#xD;
          -  Cardiac pacemaker inserted in the last 2 days&#xD;
&#xD;
          -  Unstable spine, femur, or pelvic fractures&#xD;
&#xD;
          -  Hemodynamic instability or severe cardiac arrhythmia (chronic AFib is not a&#xD;
             contraindication). Mean arterial pressure lower than 60 mm Hg, &gt;1 vasopressor agent or&#xD;
             Norepinephrine equivalent dose &gt;0.06 mcg/kg/min&#xD;
&#xD;
          -  Pregnant women&#xD;
&#xD;
          -  Single anterior chest tube with air leaks&#xD;
&#xD;
          -  Burns on more than 20 % of the body surface&#xD;
&#xD;
          -  Delirium or altered mental status increasing fall risk while in prone position.&#xD;
&#xD;
          -  End-of-life decision before inclusion&#xD;
&#xD;
          -  Subject deprived of freedom, minor, subject under a legal protective measure&#xD;
&#xD;
          -  Unable to actively participate in Assisted Manual Pronation Therapy per nursing&#xD;
             assessment&#xD;
&#xD;
          -  Lacking capacity to provide informed consent.&#xD;
&#xD;
          -  Individuals with mechanical or vascular disease precluding safe displacement of the&#xD;
             head, for example: cervical spinal fusion, limited range of motion, or severe vascular&#xD;
             occlusive disease of the head and neck.&#xD;
&#xD;
          -  Body mass index (BMI) greater than 70 kg/m2, or unable to actively participate in&#xD;
             Assisted Manual Pronation Therapy per nursing assessment at any BMI value.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>110 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Gustavo Cortes Puentes, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Mayo Clinic</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Mayo Clinic in Rochester</name>
      <address>
        <city>Rochester</city>
        <state>Minnesota</state>
        <zip>55905</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Gustavo A Cortes Puentes, MD</last_name>
      <phone>507-284-3104</phone>
      <email>CortesPuentes.Gustavo@mayo.edu</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>https://www.mayo.edu/research/clinical-trials</url>
    <description>Mayo Clinic Clinical Trials</description>
  </link>
  <verification_date>January 2021</verification_date>
  <study_first_submitted>July 14, 2020</study_first_submitted>
  <study_first_submitted_qc>January 3, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">January 5, 2021</study_first_posted>
  <last_update_submitted>January 3, 2021</last_update_submitted>
  <last_update_submitted_qc>January 3, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">January 5, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Mayo Clinic</investigator_affiliation>
    <investigator_full_name>Gustavo A. Cortes Puentes</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Respiratory Insufficiency</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

